Dr. Melanie Thomas, an expert in the field of gastroenterology, discusses two clinical trials on the horizon at the Hollings Cancer Center of MUSC, each of which focuses on therapy for primary liver cancer. She offers details on the methodology of the clinical studies and notes five other sites around the United States that will augment the work performed at MUSC. Dr. Thomas also identifies eligibility criteria for participation in these studies. To conclude this gastroenterological cancer podcast, Dr. Thomas points to the importance of research in the field of primary liver cancer, which has been previously under-represented.